Chiasma Investors Want Bond From 'Frivolous' Deal Objectors
Chiasma investors fought back Wednesday against a pair of objectors to the $18.7 million settlement of a shareholder suit against the biopharmaceutical company, arguing that they lack standing to appeal and...To view the full article, register now.
Already a subscriber? Click here to view full article